Stephen Colvill is Executive Director and co-founder of RISCS, Inc., an independent, standardized rating organization that promotes supply chain resilience for critical medications. Prior to co-founding RISCS, Inc., Stephen worked in the pharmaceutical manufacturing industry in a variety of leadership roles in business analytics, marketing, portfolio management, and supply chain at Pfizer and Hospira.
The publication of the Stigler Center at
The University of Chicago Booth School of Business
ProMarket is dedicated to discussing how competition tends to be subverted by special interests.
The posts represent the opinions of their writers, not necessarily those of the University of Chicago, the Booth School of Business, or its faculty.
For more information, please visit ProMarket Policy.